Dai Ichi Life Insurance Company, LTD Zai Lab LTD Transaction History

Dai Ichi Life Insurance Company, LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$54.9 - $105.21 $203,130 - $389,277	-3,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $200,176 - $288,000	1,600 Added 76.19%	3,700 $655,000
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $265,167 - $402,591	2,100 New	2,100 $280,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.51B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.